The expression of Mas-receptor of the renin–angiotensin system in the human eye

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 253, Issue 7, 2015, Pages 1053-1059

  Vaajanen, A ^a,b   Kalesnykas, G ^b,c   Vapaatalo, H ^d   Uusitalo, H ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c Experimentica Ltd   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Ang II; Ang(1 7); Glaucoma; Human eye; Immunohistochemistry; Mas receptor; RAS

Indexed keywords

ANGIOTENSIN[1-7]; MAS RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); G PROTEIN COUPLED RECEPTOR; LIGAND; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ARTICLE; CELLULAR DISTRIBUTION; CILIARY BODY; CILIARY BODY EPITHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; EYE; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRABECULAR MESHWORK; ANTERIOR EYE SEGMENT; CHOROID; ENZYME IMMUNOASSAY; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PHYSIOLOGY; RETINA;

ANGIOTENSIN I; ANTERIOR EYE SEGMENT; CHOROID; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY; LIGANDS; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; RETINA;

EID: 84933177553     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-015-2952-z     Document Type: Article

References (24)

1. Bader M, Peters J, Baltatu O, Müller DN, Luft FC, Ganten D (2001) Tissue renin–angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79:76–102
2. Kramkowski K, Mogielnicki A, Buczko W (2006) The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 57:529–539
3. Young D, Waitches G, Birchmeier C, Fasano O, Wigler M (1986) Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45(5):711–719
4. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T (2003) Angiotensin (1–7) is an endogenous ligand for the G-protein-coupled receptor Mas. Proc Natl Acad Sci U S A 8:8258–8263
5. Paul M, Poyan Mehr A, Kreutz R (2006) Physiology of local renin–angiotensin systems. Review. Physiol Rev 86:747–803
6. Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF (1986) Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci U S A 83:7552–7556
7. Garg M, Angus PW, Burrell LM, Herath C, Gibson PR, Lubel JS (2012) Review article: the pathophysiological roles of the renin–angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther 35:414–428
8. Danser AHJ, Derkx FHM, Admiraal PJJ, Deinum J, de Jong PTVM, Schalekamp MADH (1994) Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 35:1008–1018
9. Foureaux G, Nogueira JC, Nogueira BS, Fulgencio GO, Menezes GB, Fernandes SO, Cardoso VN, Fernandes RS, Oliveira GP, Franca JR, Faraco AA, Raizada MK, Ferreira AJ (2013) Antiglaucomatous effects of the activation of intrinsic angiotensin-converting enzyme 2. Invest Ophthalmol Vis Sci 54:4296–4306
10. Giese MJ, Speth RC (2014) The ocular renin–angiotensin system: a therapeutic target for the treatment of ocular disease. Pharmacol Ther 142:11–32
11. Luhtala S, Vaajanen A, Oksala O, Valjakka J, Vapaatalo H (2009) Activities of angiotensin-converting enzymes 1 (ACE1) and 2 (ACE2) and inhibition by bioactive peptides in porcine ocular tissues. J Ocul Pharmacol 25:23–28
12. Senanayake PD, Drazba J, Shadrach K, Milsted A, Rungger-Brandle E, Nishiyama K, Miura S, Karnik S, Sears JE, Hollyfield JG (2007) Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 48:3301–3311
13. Vaajanen A, Luhtala S, Oksala O, Vapaatalo H (2008) Does the renin–angiotensin system also regulate intraocular pressure? Ann Med 10:1–10
14. Wagner J, Danser AHJ, Derkx FH, de Jong TV, Paul M, Mullins JJ, Schalekamp MA, Ganten D (1996) Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme RNA expression in the human eye: evidence for an intraocular renin–angiotensin system. Br J Ophthalmol 80:159–163
15. Vaajanen A, Lakkisto P, Virtanen I, Kankuri E, Oksala O, Vapaatalo H, Tikkanen I (2010) Angiotensin receptors in the eyes of arterial hypertensive rats. Acta Ophthalmol 88:431–438
16. Young D, O'Neill K, Jessell T, Wigler M (1988) Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proc Natl Acad Sci U S A 85(14):5339–5342
17. Kitaoka T, Sharif M, Hanley MR, Hjelmeland LM (1994) Expression of the MAS proto-oncogene in the retinal pigment epithelium of the rhesus macaque. Curr Eye Res 13(5):345–351
18. Paulis L, Unger T (2010) Novel therapeutic targets for hypertension. Nat Rev Cardiol 7:431–441
19. Ferrario CM (2011) ACE2: more of Ang-(1–7) or less Ang II? Curr Opin Nephrol Hypertens 20:1–6
20. Ferreira AJ, Murça TM, Fraga-Silva RA, Castro CH, Raizada MK, Santos RA (2012) New cardiovascular and pulmonary therapeutic strategies based on the angiotensin-converting enzyme 2/angiotensin-(1–7)/mas receptor axis. Int J Hypertens 2012:147825
21. Vaajanen A, Vapaatalo H, Kautiainen H, Oksala O (2008) Angiotensin (1–7) reduces intraocular pressure in the normotensive rabbit eye. Invest Ophthalmol Vis Sci 49:2557–2562
22. Costagliola C, Di Benedetto R, De Caprio L, Verde R, Mastropasqua L (1995) Effect of oral captopril (SQ 14225) on intraocular pressure in man. Eur J Ophthalmol 5:19–25
23. Costagliola C, Verolino M, de Rosa ML, Iaccarino G, Ciancaglini M, Mastropasqua L (2000) Effect of oral losartan potassium on intraocular pressure in normotensive and glaucomatous human subjects. Exp Eye Res 71:167–171
24. Mehta A, Lyer L, Parmar S, Shah G, Goyal R (2010) Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits. Can J Physiol Pharmacol 88:595–600